Clincosm LogoSign in Get a demo

hodgkin's lymphoma

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Communication Skills Intervention to Promote Transition Into

Active, not recruiting
  • Hodgkin's Lymphoma
  • Diffuse Large B-cell Lymphoma
    • Tampa, Florida
    • +8 more
    Dec 19, 2022

    Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

    Recruiting
    • Hodgkin's Lymphoma
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 5, 2022

    Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

    Recruiting
    • Microsatellite High Cancers
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 8, 2022

    Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

    Recruiting
    • Hematological Malignancies
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Apr 12, 2022

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

    Active, not recruiting
    • Non-Hodgkin's Lymphoma
    • Hodgkin's Lymphoma
    • CAR.CD30 T cells
    • Chapel Hill, North Carolina
    • +2 more
    Mar 16, 2022

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • autologous CAR.CD30 EBV specific-CTLs
    • Houston, Texas
    • +1 more
    Feb 4, 2022

    Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 10, 2020

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Worldwide (HCD122)

    Completed
    • Non-Hodgkin's Lymphoma
    • Hodgkin's Lymphoma
    • Chicago, Illinois
    • +27 more
    Dec 11, 2020

    Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

    Completed
    • Hematological Neoplasms
    • +19 more
    • Scottsdale, Arizona
    • +9 more
    May 11, 2020

    Relapsed or Refractory Lymphoproliferative Malignancies, Hodgkin's Lymphoma, Peripheral T-cell Lymphoma Trial in United States

    Completed
    Has Results
    • Relapsed or Refractory Lymphoproliferative Malignancies
    • +4 more
    • Pralatrexate Injection
    • +3 more
    • Los Angeles, California
    • +14 more
    Dec 27, 2019

    Hodgkin's Lymphoma Trial in United States (Entinostat)

    Terminated
    Has Results
    • Hodgkin's Lymphoma
    • Beverly Hills, California
    • +5 more
    Oct 3, 2019

    Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

    Completed
    Has Results
    • Acute Leukemia
    • +8 more
    • Tacrolimus (ARM with Methotrexate)
    • +7 more
    • Duarte, California
    • +29 more
    Jan 2, 2019

    Breast Cancer, Hypercalcemia of Malignancy, Colon Cancer Trial in Worldwide (denosumab)

    Completed
    Has Results
    • Breast Cancer
    • +15 more
    • Encinitas, California
    • +23 more
    Sep 20, 2018

    Hodgkin's Lymphoma Trial in Canada, United States (MGCD0103)

    Terminated
    • Hodgkin's Lymphoma
    • Chicago, Illinois
    • +4 more
    Jun 5, 2015

    Blood And Marrow Transplantation, Leukemia, Lymphoma Trial in United States (Fludarabine, Clofarabine, Busulfan, ATG, TBI

    Unknown status
    • Blood And Marrow Transplantation
    • +6 more
    • Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative)
    • Fludarabine, Melphalan, ATG (Reduced Intensity)
    • La Jolla, California
    • +3 more
    Nov 14, 2013

    Hodgkin's Lymphoma Trial in Houston (Obatoclax mesylate (GX15-070MS))

    Completed
    • Hodgkin's Lymphoma
    • Obatoclax mesylate (GX15-070MS)
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 3, 2012

    Lymphoma, Malignant, Hodgkin's Lymphoma, B Cell Lymphoma Trial in Houston (SB1518)

    Completed
    • Lymphoma, Malignant
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Apr 19, 2012

    Hodgkin's Lymphoma Trial in New York, Houston (TNX-650)

    Unknown status
    • Hodgkin's Lymphoma
    • New York, New York
    • +1 more
    May 8, 2008

    Lymphoma, Non-Hodgkin, Hodgkin's Lymphoma Trial in United States (ABT-510 - Thrombospondin-1 Mimetic)

    Completed
    • Lymphoma, Non-Hodgkin
    • Hodgkin's Lymphoma
    • ABT-510 - Thrombospondin-1 Mimetic
    • Phoenix, Arizona
    • +13 more
    Aug 13, 2007